# Delivery Order #SPE2DP26F7637

DMS Pharmaceutical Group Loperamide Delivery Order

**Buyer:** Defense Logistics Agency

**Award Amount:** $2,387.00
**Ceiling:** $2,387.00

**Awarded:** July 14, 2026
**Period of Performance:** Jul 14, 2026 - Jul 14, 2026

**Identifier:** SPE2DP26F7637
**NAICS:** 424210

This is a delivery order under a long-term pharmaceutical supply contract held by DMS Pharmaceutical Group Inc., a pharmaceutical distributor. It covers the supply of loperamide hydrochloride capsules, an anti-diarrheal medication, for federal healthcare needs. The order contributes to the parent contract’s broader effort to maintain access to a range of essential medicines. The parent contract is a multi-year arrangement, with performance underway; this order has a brief, single-day performance period. The order’s award date is not separately provided. The available information does not identify whether this order was competitively awarded or sole-source, nor does it specify a contract vehicle beyond the parent supply contract, acquisition programs, subcontractors, prior related orders, or an original solicitation.

### Description

8512239563!LOPERAMIDE HYDROCHLORIDE CAPS

[View original record](https://www.usaspending.gov/award/CONT_AWD_SPE2DP26F7637_9700_SPE2DX25D9900_9700)